New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Hyderabad (Telangana) [India], August 14 (ANI): Hyderabad-based pharmaceuticals and biologics firm Biological E. Limited (BE) on Thursday entered into an agreement with Janssen Pharmaceutica NV, part of pharma major Johnson & Johnson, for the creation and enhancement of manufacturing cap
Mumbai (Maharashtra) [India], Aug 7 (ANI): Pharma major Lupin Ltd has reported 60 per cent year-on-year decline in its net profit for the April to June quarter at Rs 107 crore.
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Mumbai (Maharashtra) [India], May 29 (ANI): Pharma major Lupin Ltd has reported 34.5 per cent rise in its consolidated net profit to Rs 389.6 crore for the January to March quarter (Q4 FY20) as compared to Rs 289.5 crore in the corresponding period of previous fiscal.
New Delhi [India], May 3 (ANI): India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma major Gilead Sciences, said Dr Nirmal K Ganguly, former Director-General, Indian Council of Medical Research (ICMR), on Saturday.
Ahmedabad (Gujarat) [India], April 20 (ANI): Pharma major Zydus Cadila said on Monday its biological therapy Pegylated Interferon alpha-2b can emerge as one of the pathways to treat COVID-19.
Mumbai (Maharashtra) [India], April 11 (ANI): Pharma major Lupin Ltd on Saturday announced a contribution of Rs 21 crore for relief efforts directed towards mitigating the COVID-19 crisis.
Paris [France], April 10 (ANI): French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.
Mumbai (Maharashtra) [India], Apr 3 (ANI): Pharma major Lupin Ltd said on Friday it has got an establishment inspection report (EIR) from the US Food and Drug Administration for its Aurangabad facility.
Mumbai (Maharashtra) [India], Jan 27 (ANI): Pharma major Lupin Ltd on Monday announced the successful completion of inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (MHRA) at its three manufacturing units in Pithampur town of Madhya Pradesh.
Mumbai (Maharashtra) [India], Dec 24 (ANI): Pharma major Lupin Ltd said on Tuesday that its Ankleshwar facility has been awarded 'Future Ready Factory of the Year' by Frost & Sullivan's India Manufacturing Excellence Awards (IMEA) 2019.